Condition
Hemolytic Disease of Newborn
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Recruiting1
Withdrawn1
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07188298Not Yet RecruitingPrimary
Risk Factors and Clinical Outcomes of Neonatal Anemia in NICU
NCT04218318Not ApplicableRecruitingPrimary
Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn
NCT00917007Withdrawn
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
NCT00004381Phase 2Completed
Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
Showing all 4 trials